Cite
APA Citation
Nishimura, R., Osonoi, T., Kanada, S., Jinnouchi, H., Sugio, K., Omiya, H., Ubukata, M., Sakai, S., & Samukawa, Y. (n.d.). effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double‐blind, placebo‐controlled, crossover study. Diabetes, obesity & metabolism, 17(8), 800–804. http://access.bl.uk/ark:/81055/vdc_100025991362.0x00001f